These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 17352101)

  • 1. Mycobacterium kansasii in HIV patients: clarithromycin and antiretroviral effects.
    Tompkins JC; Witzig RS
    Int J Tuberc Lung Dis; 2007 Mar; 11(3):331-7. PubMed ID: 17352101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycobacterium kansasii disease among patients infected with human immunodeficiency virus type 1: improved prognosis in the era of highly active antiretroviral therapy.
    Santin M; Alcaide F
    Int J Tuberc Lung Dis; 2003 Jul; 7(7):673-7. PubMed ID: 12870689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections with Mycobacterium kansasii in the Academic Medical Center in Amsterdam: the changing clinical spectrum since the start of the HIV epidemic].
    van der Meer JT; Kerssemakers SP; van Steenwijk RP; Kuijper EJ
    Ned Tijdschr Geneeskd; 1998 Apr; 142(17):965-9. PubMed ID: 9623171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
    Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
    Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy.
    Dheda K; Lampe FC; Johnson MA; Lipman MC
    J Infect Dis; 2004 Nov; 190(9):1670-6. PubMed ID: 15478074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS-associated cryptococcosis: a comparison of epidemiology, clinical features and outcome in the pre- and post-HAART eras. Experience of a single centre in Italy.
    Antinori S; Ridolfo A; Fasan M; Magni C; Galimberti L; Milazzo L; Sollima S; Adorni F; Giuliani G; Galli M; Corbellino M; Parravicini C
    HIV Med; 2009 Jan; 10(1):6-11. PubMed ID: 19125961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disease caused by Mycobacterium kansasii in patients with HIV infection].
    Urkijo JC; Montejo M; Aguirrebengoa K; Urra E; Aguirre C
    Enferm Infecc Microbiol Clin; 1993 Mar; 11(3):120-5. PubMed ID: 8499509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of recurrent nontyphoid Salmonella bacteremia in HIV-infected patients in the era of highly active antiretroviral therapy and an increasing trend of fluoroquinolone resistance.
    Hung CC; Hung MN; Hsueh PR; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Huang YT; Lo YC; Hsiao CF; Chang SC
    Clin Infect Dis; 2007 Sep; 45(5):e60-7. PubMed ID: 17682981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
    Griffith DE; Brown-Elliott BA; Wallace RJ
    Clin Infect Dis; 2003 Nov; 37(9):1178-82. PubMed ID: 14557961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mortality prediction in pulmonary Mycobacterium kansasii infection and human immunodeficiency virus.
    Marras TK; Morris A; Gonzalez LC; Daley CL
    Am J Respir Crit Care Med; 2004 Oct; 170(7):793-8. PubMed ID: 15215152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
    Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
    J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium kansasii septic arthritis: French retrospective study of 5 years and review.
    Bernard L; Vincent V; Lortholary O; Raskine L; Vettier C; Colaitis D; Mechali D; Bricaire F; Bouvet E; Sadr FB; Lalande V; Perronne C
    Clin Infect Dis; 1999 Dec; 29(6):1455-60. PubMed ID: 10585795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological, clinical and therapeutic features of AIDS-related Mycobacterium kansasii infection during the HIV pandemic: an 11-year follow-up study.
    Manfredi R; Nanetti A; Valentini R; Ferri M; Morelli S; Calza L
    HIV Med; 2004 Nov; 5(6):431-6. PubMed ID: 15544696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit.
    Palacios R; Hidalgo A; Reina C; de la Torre M; Márquez M; Santos J
    HIV Med; 2006 Apr; 7(3):193-6. PubMed ID: 16494634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ocular manifestations in patients with human immunodeficiency virus infection before and after the introduction of highly active antiretroviral therapy].
    Mesarić B; Lisić M; Kniewald T; Ugrinović N; Begovac J
    Lijec Vjesn; 2005; 127(5-6):123-8. PubMed ID: 16281473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long term survival after Rhodococcus equi pneumonia in a patient with human immunodeficiency virus infection in the era of highly active antiretroviral therapy: case report and review].
    Vladusić I; Krajinović V; Begovac J
    Acta Med Croatica; 2006 Jun; 60(3):259-63. PubMed ID: 16933840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.